EFFICACY OF DIFFERENT CRYOBALLOON ABLATION STRATEGIES IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

Aim. To study the effectiveness of “extended” cryoballon ablation in patients with a persistent form of atrial fibrillation (AF) and to determine the risk factors for AF recurrence after cryoablation. Methods. The study included 89 patients (62±10 years, 24 [27%] men) with a persistent form of AF. The patients were randomized into two groups: in the 1st, the pulmonary veins (PV) cryoablation was performed (n=48 [53.9%]); in the 2nd, the PV cryoablation was performed in combination with cryoablation of the posterior wall of the left atrium (n=41 [46.1%]). The number of patients at high risk of thromboembolic events predominated in Group 2 (p=0,03). There is a high frequency of taking antiarrhythmic drugs of class III in this group (p=0.018). The follow‐up period was 12 months. Clinical efficacy was assessed during a survey and daily ECG monitoring at face‐to‐face visits after 3, 6 and 12 months. Results. Antral isolation of PV was achieved in all 89 (100%) patients in both groups. In group 2, the average number of applications in the posterior wall of the PV was 10 [9; 13]. The effectiveness of cryoablation in group 1 by the end of the 12‐month follow‐up period was 54.2%, in group 2‐56.1%. The complication rate (6.7%) in both groups did not differ statistically (p=0.683). The risk of arrhythmia recurrence didn’t depend on the strategy of cryoablation in postab‐lation period (p=0.834). When conducting a single‐factor analysis, a statistically significant effect on the probability of AF recurrence in the period of 3‐12 months in group 1 was caused by AF recurrence in the blind period (95% confidence interval (CI): 1.5‐27.7, p=0.013), in group 2 belonging to the female sex (95% CI: 1.2‐24.6, p=0.032) and AF relapse in the blind period (95% CI: 1.5‐128.5, p=0.020). During multivariate analysis in group 2, a statistically significant influence on the risk of AF recurrence in the period of 3‐12 months was exerted by belonging to the female sex (hazard ratio (HR) 7.84; 95% CI 1478‐42,23; p=0.016) and the presence of early AF recurrence (HR 20.36; 95% CI 1.99‐208.23; p=0.011). Conclusion. Extended cryoablation in terms of efficiency and safety was comparable with the standard cryoablation. Early recurrence of AF (in the first 3 months after the intervention) turned out to be an independent risk factor for AF recurrence in the long‐term period up to 12 months after cryoablation in both groups.